SFXN3 and acute myeloid leukemia: SFXN3 expression levels in CHOL, HNSC, KIRC, acute myeloid leukemia (LAML), PAAD, PCPG, and sarcoma (SARC) were upregulated compared with those in the corresponding normal controls in the GEPIA database (all p < 0.05, Figure S1B).